Global Balloon-expandable Vascular Stent Market Size By Type (Metallic Stents, Cobalt Chromium), By Application (Hospitals And Cardiac Centers, Ambulatory Surgical Centers), By Region, And Segment For...

The Global Balloon-expandable Vascular Stent Market was valued at USD 3.9 billion in 2023 and is expected to reach USD 7.4 billion by 2031, growing at a CAGR of 8.3% during the forecast period (2023–2031). This growth is driven by the rising prevalence of cardiovascular diseases (CVDs), increasing geriatric population, and technological advancements in stent designs. Balloon-expandable vascular stents are widely used in interventional cardiology for restoring blood flow in blocked or narrowed vessels, making them essential in the treatment of coronary and peripheral artery diseases.

Drivers:

Rising Cardiovascular Disease Burden

Globally, cardiovascular conditions remain a leading cause of mortality. The growing patient pool requiring minimally invasive procedures is propelling the demand for balloon-expandable stents, which offer precise placement and effective vessel support.

Technological Advancements in Stent Design

Advances in stent materials (e.g., cobalt-chromium alloys) and drug-eluting coatings are enhancing product performance, reducing restenosis rates, and promoting faster recovery. This innovation is accelerating market adoption globally.

Increasing Geriatric Population

As age is a major risk factor for vascular diseases, the expanding elderly demographic is increasing the need for effective vascular interventions, directly influencing the demand for balloon-expandable stents.

Restraints:

High Costs and Reimbursement Challenges

The high cost of stent procedures, combined with variable reimbursement policies across countries, limits accessibility—particularly in low-income and developing regions.

Risk of Post-operative Complications

Despite improvements, complications such as stent thrombosis, restenosis, and late-stage infections persist, posing challenges to widespread clinical acceptance and long-term success.

Opportunity:

Emerging Markets and Healthcare Infrastructure Development

Expanding healthcare access and increased government investment in healthcare infrastructure in countries like India, Brazil, and China are creating significant growth opportunities for stent manufacturers.

Integration with Imaging Technologies

The integration of stents with advanced imaging modalities such as OCT (optical coherence tomography) and IVUS (intravascular ultrasound) supports better procedural planning and outcome prediction, fostering growth potential.

Market by System Type Insights:

Drug-Eluting Balloon-expandable Stents

This segment dominated the market in 2023 due to its ability to minimize restenosis rates. These stents release antiproliferative drugs at the lesion site, providing therapeutic benefits alongside mechanical support.

Bare Metal Balloon-expandable Stents

While less commonly used today, bare metal stents are still preferred in specific cases due to their lower cost and compatibility with patients who cannot undergo long-term antiplatelet therapy.

Market by End-use Insights:

Hospitals

Hospitals held the largest share of end-use revenue in 2023, driven by the increasing number of interventional procedures conducted in high-volume healthcare institutions with advanced facilities.

Cardiac Centers and Specialty Clinics

These centers are witnessing faster growth due to their specialized focus, reduced wait times, and increasing preference for outpatient interventions in developed markets.

Market by Regional Insights:

North America

North America led the global market in 2023, supported by high healthcare expenditure, widespread adoption of advanced cardiovascular treatments, and strong presence of key market players.

Asia-Pacific

Asia-Pacific is expected to register the highest growth during the forecast period. Rising healthcare investments, growing patient awareness, and expanding access to cardiovascular care are fueling this momentum.

Competitive Scenario:

Key players operating in the global balloon-expandable vascular stent market include:

Abbott Laboratories

Medtronic plc

Boston Scientific Corporation

BIOTRONIK SE & Co. KG

Terumo Corporation

B. Braun Melsungen AG

MicroPort Scientific Corporation

Cook Medical

Meril Life Sciences

Cordis (a Cardinal Health company)

These companies are actively investing in R&D, strategic partnerships, and geographic expansion. For example:

In 2023, Abbott launched a new generation of drug-eluting balloon-expandable stents with enhanced flexibility and deliverability.

In 2024, Boston Scientific received CE Mark approval for a biodegradable balloon-expandable stent designed for peripheral artery disease.

Medtronic announced a collaboration with imaging solution providers to integrate real-time diagnostics during stent deployment procedures.

Scope of Work – Global Balloon-expandable Vascular Stent Market

Report Metric Details

Market Size (2023) USD 3.9 billion

Projected Market Size (2031) USD 7.4 billion

CAGR (2023–2031) 8.3%

Market Segments By System Type (Drug-Eluting, Bare Metal), By End-Use (Hospitals, Cardiac Centers), By Region

Growth Drivers Rising CVD prevalence, aging population, stent innovations

Opportunities Emerging market expansion, integration with imaging tech

Key Market Developments:

Jan 2024: Abbott Laboratories received FDA approval for its next-generation balloon-expandable drug-eluting stent with enhanced lesion crossability.

Aug 2023: Boston Scientific launched a global clinical trial for a bioresorbable stent platform targeting coronary artery disease.

May 2023: Terumo Corporation expanded its cardiovascular R&D center in Japan, focusing on next-gen balloon-expandable systems.

FAQs:

1) What is the current market size of the Global Balloon-expandable Vascular Stent Market?

The market was valued at USD 3.9 billion in 2023.

2) What is the major growth driver of the Global Balloon-expandable Vascular Stent Market?

The major driver is the rising prevalence of cardiovascular diseases and increasing demand for minimally invasive procedures.

3) Which is the largest region during the forecast period in the Global Balloon-expandable Vascular Stent Market?

North America holds the largest market share due to advanced healthcare infrastructure and high procedure volumes.

4) Which segment accounted for the largest market share in the Global Balloon-expandable Vascular Stent Market?

The drug-eluting stent segment accounted for the largest share in 2023.

5) Who are the key market players in the Global Balloon-expandable Vascular Stent Market?

Key players include Abbott Laboratories, Medtronic, Boston Scientific, BIOTRONIK, Terumo, and B. Braun.